Smilow Cancer Hospital at Yale New Haven and Saint Francis Care announce the launch of new partnership in Hartford
New Haven, Hartford, CT (June 15, 2015) – Saint Francis Care, parent of Saint Francis Hospital and Medical Center, and Yale New Haven Hospital today announced the launch of a new partnership at Saint Francis, creating an integrated oncology services program to better serve the greater Hartford community. This new partnership brings the clinical program of Smilow Cancer Hospital at Yale New Haven to the Saint Francis Campus.
This partnership gives Saint Francis patients enhanced access to groundbreaking clinical trials, broader screening and diagnostic tools, treatment options, expanded psychosocial support and enhanced pain management therapies. Clinicians at Saint Francis will now follow expanded treatment planning procedures and patient support systems that have been so successful at Smilow in meeting high standards for patient satisfaction and national quality of care targets.
“Saint Francis is known for exceptional patient and family centered cancer care,” said Thomas Lynch, M.D., director, Yale Cancer Center; physician-in-chief, Smilow Cancer Hospital at Yale New Haven. “The cultural fit with Smilow is perfect – both institutions have outstanding doctors, nurses, and caregivers and are laser focused on research designed to cure more cancers. Smilow at Saint Francis will define the very best in cancer care, incorporating cancer genetics and personalized precision medicine to bring more cures to more patients.”
Saint Francis and Yale New Haven Hospitals share a common vision for ensuring that each patient has access to patient-centered, high-quality care that delivers the region’s best treatment value
Last November, Saint Francis and Smilow Cancer Hospital at Yale New Haven began to explore an oncology services relationship that would build off an existing partnership. Today we are proud to launch this new partnership that will provide integrated and enhanced care in outpatient medical oncology services and hematology.
“This alliance allows us to serve our patients better,” said Christopher M. Dadlez, president and CEO, Saint Francis. “This opportunity to work with Smilow Cancer Hospital creates a model of integration that will transform cancer care at state, regional and even national levels.”
Smilow Cancer Hospital and Yale Cancer Center are leading research that is improving the cure rate of advanced cancer and defining the future of personalized cancer medicine. In addition to this exciting new campus, Smilow Cancer Hospital at Yale New Haven operates 11 cancer care centers across the state. The care centers enable Smilow clinicians to deliver high-quality healthcare to patients in ambulatory settings close to home. Smilow Cancer Hospital at Yale New Haven is one of the most comprehensive cancer facilities in the country. It is affiliated with Yale Cancer Center, a National Cancer Institute Comprehensive Cancer Center – one of only 41 in the nation and the only one in Connecticut with this designation.
Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org
New Haven, CT (Nov. 25, 2019) – The Commission on Cancer (CoC), a quality program of the American College of Surgeons (ACoS), has granted three-year accreditation with commendation to the cancer program at Smilow Cancer Hospital (SCH) at Yale New Haven.
Westerly, RI (October 29, 2019) – Westerly Hospital celebrated the opening of its new Smilow Cancer Hospital Care Center Monday, the second new unit to open at the hospital in as many months.
New Haven, Conn. — One of the most promising new generations of cancer treatment called Chimeric Antigen Receptor (CAR) T-cell therapy is now available for patients at Smilow Cancer Hospital.